Full-Time

Field Reimbursement Manager

Posted on 11/11/2024

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops and commercializes biosimilars for healthcare

Compensation Overview

$165k - $190k/yr

Senior

Chicago, IL, USA

Candidate must reside within assigned territory and have the ability to travel up to 70%.

Category
Insurance
Finance & Banking
Required Skills
Inventory Management
Requirements
  • 5+ years of commercial experience in the pharmaceutical or biotech industry.
  • 3+ years of experience in healthcare coverage, coding and/or reimbursement.
  • Direct experience with Buy and Bill products, Medicare Part B and Miscellaneous J-Codes required.
  • Bachelor's degree from a four-year college or university.
Responsibilities
  • Partner with internal and external stakeholders to identify, anticipate and address patient and practice reimbursement issues.
  • Collaborate with Field Sales to identify facilities and practices that need reimbursement education and support regarding Coherus products.
  • Provide insights and updates regarding product and support service integration at accounts.
  • Educate facility staff on policies related to product acquisition, inventory management, and all payer policies related to support full integration of product into the practice workflow.
  • Provide coverage, coding, and reimbursement information to key staff members (i.e., practice administrators, reimbursement staff, and providers) in order to appropriately support patient access.
  • Collaborate with field facing 'One Team' to compliantly share insights into customer needs, potential barriers, and payer issues/opportunities for access at practices.
  • Communicate and explain payer policy updates or system changes that impact access.
  • Proactively communicate Coherus COMPLETE™ so that office staff is fluent in how to use patient access programs and services.
  • Address questions associated with patient coverage, access, and reimbursement from accounts in collaboration and coordination with patient services as directed by policy and procedure.
  • Conduct frequent claim reviews with practices to ensure appropriate reimbursement of Coherus products.
  • Maintain a deep understanding of Coherus policies and requirements and perform the role in a compliant manner consistent with company guidance.
  • Keep abreast of customer and market access industry trends.
Desired Qualifications
  • Oncology experience strongly preferred.

Coherus BioSciences develops and sells biosimilars, which are highly similar versions of approved biologic medicines used to treat various diseases. These biosimilars are designed to be as effective and safe as the original products but are offered at a lower cost, making them more affordable for patients and healthcare systems. The company focuses on improving patient lives by expanding access to these essential treatments, helping to offset rising healthcare costs. Coherus operates in the biopharmaceutical market, serving healthcare providers, hospitals, and patients. Their business model includes rigorous research, development, and regulatory approval processes to ensure high-quality products. By providing cost-effective alternatives to original biologics, Coherus aims to enhance healthcare accessibility and affordability, positioning itself as a leader in the biosimilar industry.

Company Size

201-500

Company Stage

IPO

Headquarters

Redwood City, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased focus on immuno-oncology enhances pipeline and market position.
  • Launch of Udenyca wearable injector device improves drug delivery systems.
  • Strategic collaborations could lead to new partnerships and investment opportunities.

What critics are saying

  • Exit from biosimilar space may lead to loss of market share.
  • 30% staff reduction could affect innovation and productivity.
  • Collaboration with Cancer Research Institute may face scientific and regulatory hurdles.

What makes Coherus BioSciences unique

  • Focus on biologic therapeutics for oncology and inflammatory diseases.
  • Expertise in process science and analytical characterization.
  • Commitment to high-quality, cost-effective biosimilars.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
PharmiWeb
May 28th, 2025
Storm Therapeutics Announces First Patient Dosed In Clinical Collaboration To Evaluate Stc-15 In Combination With Loqtorzi® And Appointment Of Atif Abbas, M.D., As Chief Medical Officer

STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer. STC-15 has demonstrated durable clinical activity and tolerability to progress into a combination study with a checkpoint inhibitor

Fierce Pharma
Apr 23rd, 2025
Coherus loses commercial chief amid exit from biosimilar space

Coherus hired Sameer Goregaoker as senior VP of immuno-oncology marketing and Loqtorzi brand lead late last year.

ETF Daily News
Mar 29th, 2025
Intech Investment Management LLC Makes New $38,000 Investment in Coherus BioSciences, Inc. (NASDAQ:CHRS)

Intech Investment Management LLC makes new $38,000 investment in Coherus BioSciences, Inc. (NASDAQ:CHRS).

Stock Titan
Feb 24th, 2025
Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

Coherus BioSciences (NASDAQ: CHRS) has announced its senior management's upcoming participation in the 45th Annual TD Cowen Health Care Conference.

PE Hub
Jul 3rd, 2024
SK Capital's Apotex to acquire Canadian rights to Toripalimab

SK Capital Partners portfolio company Apotex has agreed to acquire the license to the Canadian rights to Toripalimab, an anti-PD-1 monoclonal antibody, from Coherus Biosciences.

INACTIVE